Filed: 11/13/2024ACC: 0001420506-24-002386
📋 What this filing means
STEMPOINT CAPITAL LP filed this quarterly 13F‑HR report disclosing 50 equity positions with a total reported market value of $334.02M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
50
Positions
$334.02M
Total AUM (reported)
28.17M
Total Shares
Allocation by class
COM$246.99M73.9%
SHS$40.92M12.3%
COM NEW$17.57M5.3%
SPON ADS$9.50M2.8%
COMMON STOCK$8.14M2.4%
CLASS A ORD SHS$4.24M1.3%
CL A ORD SHS$3.59M1.1%
Portfolio Concentration
Top 3$86.72M26.0%
4–10$100.89M30.2%
11–25$95.29M28.5%
Rest$51.12M15.3%
Top 3 weight
26.0%
Top 10 weight
56.2%
Voting Authority Distribution
Total shares with voting rights: 28.17M
Sole
Full voting authority
24.73M
shares
% of voting shares87.8%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
3.44M
shares
% of voting shares12.2%
Investment Discretion (by position count)
Sole50
Shared0
Other0
Dominant voting typeSole · 87.8% of voting shares
Institutional Holdings50
Rows:
SYNDAX PHARMACEUTICALS INC
SOLEShares1.96M
TypeSH
Market value$33.71M
10.09%
Sole
1.65M
Shared
0.00
None
306.36K
ROIVANT SCIENCES LTD
SOLEShares2.77M
TypeSH
Market value$31.96M
9.57%
Sole
2.61M
Shared
0.00
None
163.39K
MERUS N V
SOLEShares421.22K
TypeSH
Market value$21.04M
6.30%
Sole
373.46K
Shared
0.00
None
47.76K
IMMUNOVANT INC
SOLEShares871K
TypeSH
Market value$19.24M
5.76%
Sole
778.26K
Shared
0.00
None
92.74K
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares2.03M
TypeSH
Market value$16.55M
4.96%
Sole
1.78M
Shared
0.00
None
249.49K
AMICUS THERAPEUTICS INC
SOLEShares1.48M
TypeSH
Market value$15.83M
4.74%
Sole
1.26M
Shared
0.00
None
225.57K
BRISTOL-MYERS SQUIBB CO
SOLEShares275.30K
TypeSH
Market value$14.24M
4.26%
Sole
275.30K
Shared
0.00
None
0.00
APPLIED THERAPEUTICS INC
SOLEShares1.81M
TypeSH
Market value$13.29M
3.98%
Sole
1.47M
Shared
0.00
None
336.47K
CRINETICS PHARMACEUTICALS IN
SOLEShares213.81K
TypeSH
Market value$10.93M
3.27%
Sole
199.19K
Shared
0.00
None
14.62K
BIOHAVEN LTD
SOLEShares216.44K
TypeSH
Market value$10.82M
3.24%
Sole
199.96K
Shared
0.00
None
16.48K
PRAXIS PRECISION MEDICINES I
SOLEShares174.03K
TypeSH
Market value$10.01M
3.00%
Sole
153.47K
Shared
0.00
None
20.57K
AUTOLUS THERAPEUTICS PLC
SOLEShares2.62M
TypeSH
Market value$9.50M
2.84%
Sole
2.03M
Shared
0.00
None
591.54K
INCYTE CORP
SOLEShares129.49K
TypeSH
Market value$8.56M
2.56%
Sole
129.49K
Shared
0.00
None
0.00
DENALI THERAPEUTICS INC
SOLEShares282.05K
TypeSH
Market value$8.22M
2.46%
Sole
244.77K
Shared
0.00
None
37.28K
DAY ONE BIOPHARMACEUTICALS I
SOLEShares506.98K
TypeSH
Market value$7.06M
2.11%
Sole
506.98K
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares1.32M
TypeSH
Market value$6.50M
1.95%
Sole
1.12M
Shared
0.00
None
196.70K
SOLENO THERAPEUTICS INC
SOLEShares123.18K
TypeSH
Market value$6.22M
1.86%
Sole
104.36K
Shared
0.00
None
18.82K
CABALETTA BIO INC
SOLEShares1.28M
TypeSH
Market value$6.03M
1.81%
Sole
1.02M
Shared
0.00
None
262.92K
IMMATICS N.V
SOLEShares449.74K
TypeSH
Market value$5.13M
1.54%
Sole
449.74K
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares86.93K
TypeSH
Market value$5.05M
1.51%
Sole
69.07K
Shared
0.00
None
17.86K
ARCELLX INC
SOLEShares60.08K
TypeSH
Market value$5.02M
1.50%
Sole
60.08K
Shared
0.00
None
0.00
VISTAGEN THERAPEUTICS INC
SOLEShares1.85M
TypeSH
Market value$4.90M
1.47%
Sole
1.59M
Shared
0.00
None
254.78K
NURIX THERAPEUTICS INC
SOLEShares203.01K
TypeSH
Market value$4.56M
1.37%
Sole
171.10K
Shared
0.00
None
31.91K
TSCAN THERAPEUTICS INC
SOLEShares860.95K
TypeSH
Market value$4.29M
1.28%
Sole
725.50K
Shared
0.00
None
135.45K
ZURA BIO LTD
SOLEShares1.04M
TypeSH
Market value$4.24M
1.27%
Sole
843.36K
Shared
0.00
None
200.81K
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.96M | SH | $33.71M 10.09% | 1.65M | 0.00 | 306.36K |
ROIVANT SCIENCES LTDSOLE | SHS | 2.77M | SH | $31.96M 9.57% | 2.61M | 0.00 | 163.39K |
MERUS N VSOLE | COM | 421.22K | SH | $21.04M 6.30% | 373.46K | 0.00 | 47.76K |
IMMUNOVANT INCSOLE | COM | 871K | SH | $19.24M 5.76% | 778.26K | 0.00 | 92.74K |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 2.03M | SH | $16.55M 4.96% | 1.78M | 0.00 | 249.49K |
AMICUS THERAPEUTICS INCSOLE | COM | 1.48M | SH | $15.83M 4.74% | 1.26M | 0.00 | 225.57K |
BRISTOL-MYERS SQUIBB COSOLE | COM | 275.30K | SH | $14.24M 4.26% | 275.30K | 0.00 | 0.00 |
APPLIED THERAPEUTICS INCSOLE | COM | 1.81M | SH | $13.29M 3.98% | 1.47M | 0.00 | 336.47K |
CRINETICS PHARMACEUTICALS INSOLE | COM | 213.81K | SH | $10.93M 3.27% | 199.19K | 0.00 | 14.62K |
BIOHAVEN LTDSOLE | COM | 216.44K | SH | $10.82M 3.24% | 199.96K | 0.00 | 16.48K |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 174.03K | SH | $10.01M 3.00% | 153.47K | 0.00 | 20.57K |
AUTOLUS THERAPEUTICS PLCSOLE | SPON ADS | 2.62M | SH | $9.50M 2.84% | 2.03M | 0.00 | 591.54K |
INCYTE CORPSOLE | COM | 129.49K | SH | $8.56M 2.56% | 129.49K | 0.00 | 0.00 |
DENALI THERAPEUTICS INCSOLE | COM | 282.05K | SH | $8.22M 2.46% | 244.77K | 0.00 | 37.28K |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 506.98K | SH | $7.06M 2.11% | 506.98K | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 1.32M | SH | $6.50M 1.95% | 1.12M | 0.00 | 196.70K |
SOLENO THERAPEUTICS INCSOLE | COM | 123.18K | SH | $6.22M 1.86% | 104.36K | 0.00 | 18.82K |
CABALETTA BIO INCSOLE | COM | 1.28M | SH | $6.03M 1.81% | 1.02M | 0.00 | 262.92K |
IMMATICS N.VSOLE | SHS | 449.74K | SH | $5.13M 1.54% | 449.74K | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 86.93K | SH | $5.05M 1.51% | 69.07K | 0.00 | 17.86K |
ARCELLX INCSOLE | COMMON STOCK | 60.08K | SH | $5.02M 1.50% | 60.08K | 0.00 | 0.00 |
VISTAGEN THERAPEUTICS INCSOLE | COM | 1.85M | SH | $4.90M 1.47% | 1.59M | 0.00 | 254.78K |
NURIX THERAPEUTICS INCSOLE | COM | 203.01K | SH | $4.56M 1.37% | 171.10K | 0.00 | 31.91K |
TSCAN THERAPEUTICS INCSOLE | COM | 860.95K | SH | $4.29M 1.28% | 725.50K | 0.00 | 135.45K |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 1.04M | SH | $4.24M 1.27% | 843.36K | 0.00 | 200.81K |
Page 1 of 2